Top 10 Companies in the Global Protein G, L, And A Resin Market (2026): Market Leaders Driving Antibody Purification

The Global Protein G, L, And A Resin Market Size was estimated at USD 847.42 million in 2023 and is projected to reach USD 1337.30 million by 2029, exhibiting a CAGR of 7.90% during the forecast period.

Market Insight Intro: The antibody purification arena is evolving as biopharmaceuticals expand and research laboratories demand higher purity and yield. Protein A, Protein G, and Protein L resins are pivotal for capturing, immobilizing, and detecting immunoglobulins, each offering distinct binding profiles across species and antibody subclasses. The surge in therapeutic antibody development, coupled with tightening regulatory purity standards, is reshaping the affinity media landscape, prompting manufacturers to innovate and diversify their product portfolios.

Global Protein G, L, And A Resin Market – View in Detailed Research Report

---

Market Size and Growth

In 2025, the market is valued at USD 910 million, with a 7.90% annual growth rate that is expected to lift the segment to USD 1.34 billion by 2029. The consistent expansion reflects the dual push from the pharmaceutical sector, which accounts for the majority of resin consumption, and the burgeoning research laboratory market that increasingly adopts automated purification workflows.

---

Product Definition

Protein A, Protein G, and Protein L resins are engineered affinity media designed to bind specific regions of immunoglobulins. Protein A targets the Fc region of IgG, Protein G binds both the Fc and Fab regions of several IgG subclasses, and Protein L attaches to kappa light chains, offering a broader species coverage. Their high binding capacity and rapid kinetics make them indispensable in both large‑scale manufacturing and small‑scale research.

---

Top 10 Companies in the Global Protein G, L, And A Resin Market

10️⃣ 1. Cytiva (Danaher)

Headquarters: Cambridge, United Kingdom
Key Offering: Protein A, Protein G, Protein L resins, and related purification kits

Cytiva leverages its extensive upstream and downstream integration to deliver resin solutions that seamlessly fit into existing chromatography platforms. Their focus on scalable production and quality control ensures that end‑users receive consistent performance across batches.

Sustainability & Growth Initiatives:

• Investing in green manufacturing processes to reduce water and energy consumption.
• Expanding digital analytics for resin performance monitoring.
• Strategic partnerships with contract manufacturing organizations to broaden market reach.

9️⃣ 2. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Protein A and Protein G resins, antibody purification systems

Merck KGaA has positioned itself as a leader in antibody purification by integrating its resin technology with advanced chromatography hardware. The company’s emphasis on high‑throughput workflows supports the growing demand for rapid biologic development.

Sustainability & Growth Initiatives:

• Deploying low‑footprint resin formulations.
• Implementing circular economy principles in resin disposal.
• Investing in AI‑driven process optimization tools.

8️⃣ 3. Purolite Corporation

Headquarters: Lake Forest, United States
Key Offering: Protein L resin, protein A and G resins, specialty affinity media

Purolite’s Protein L resin has become a go‑to choice for laboratories seeking broad species coverage, especially in non‑human antibody research. The company’s commitment to product reliability has earned it a strong foothold in both academic and industrial settings.

Sustainability & Growth Initiatives:

• Adoption of biodegradable resin supports.
• Enhanced recycling programs for used media.
• Expansion into emerging markets through localized production facilities.

7️⃣ 4. Thermo Fisher Scientific

Headquarters: Waltham, United States
Key Offering: Protein A, Protein G, Protein L resins, automated purification systems

Thermo Fisher Scientific combines its resin technology with proprietary chromatography systems, delivering end‑to‑end solutions that streamline antibody purification from discovery to manufacturing. Their global distribution network ensures rapid delivery and support.

Sustainability & Growth Initiatives:

• Carbon‑neutral manufacturing commitments.
• Development of reusable resin cartridges.
• Investments in machine learning for process scalability.

6️⃣ 5. Repligen Corporation

Headquarters: Waltham, United States
Key Offering: Protein A, Protein G, Protein L resins, and custom affinity media

Repligen focuses on delivering high‑performance resins tailored to specific antibody subclasses, enabling precise purification strategies. Their strong R&D pipeline drives continuous improvements in binding capacity and flow‑through performance.

Sustainability & Growth Initiatives:

• Implementation of renewable energy in production facilities.
• Partnerships with academic institutions for technology transfer.
• Development of modular resin systems for scalable operations.

5️⃣ 6. GenScript

Headquarters: Singapore
Key Offering: Protein L resin, antibody purification kits, custom antibody production

GenScript’s Protein L resin is renowned for its compatibility with a wide range of antibody formats, supporting both research and therapeutic antibody development. The company’s integrated services extend from expression to purification, creating a seamless workflow for clients.

Sustainability & Growth Initiatives:

• Eco‑friendly resin formulations.
• Investment in cloud‑based process monitoring.
• Strategic alliances with biotech startups.

4️⃣ 7. Abcam

Headquarters: Cambridge, United Kingdom
Key Offering: Protein A and Protein G resins, antibody detection reagents

Abcam’s resin portfolio is complemented by its extensive antibody catalog, positioning the company as a one‑stop resource for researchers. The focus on high‑quality, validated reagents supports reproducibility in scientific studies.

Sustainability & Growth Initiatives:

• Reduction of single‑use plastics in packaging.
• Adoption of waste‑to‑energy processes.
• Expansion of global distribution centers.

3️⃣ 8. GE Healthcare Life Sciences

Headquarters: Chicago, United States
Key Offering: Protein A and Protein G resins, integrated chromatography systems

GE Healthcare’s affinity media are engineered for high binding capacity and rapid elution, catering to both large‑scale biomanufacturing and high‑throughput laboratory workflows. Their strong engineering background translates into robust product performance.

Sustainability & Growth Initiatives:

• Carbon‑neutral facility operations.
• Development of recyclable resin supports.
• Investment in digital process control.

2️⃣ 9. Sartorius AG

Headquarters: Göttingen, Germany
Key Offering: Protein A, Protein G, Protein L resins, chromatography modules

Sartorius delivers affinity media that integrate seamlessly with its modular chromatography platforms, offering flexibility across different production scales. Their focus on process standardization supports global supply chains.

Sustainability & Growth Initiatives:

• Energy‑efficient manufacturing processes.
• Recycling programs for spent media.
• Expansion of R&D centers in Asia.

1️⃣ 10. MilliporeSigma

Headquarters: Burlington, United States
Key Offering: Protein A, Protein G, Protein L resins, antibody purification kits

MilliporeSigma’s affinity resins are supported by a comprehensive catalog of antibody reagents, providing researchers with a unified platform for discovery and development. The company’s global footprint ensures rapid access to reagents worldwide.

Sustainability & Growth Initiatives:

• Zero‑waste manufacturing targets.
• Digital supply chain transparency.
• Collaborations with academic labs for novel resin development.

---

Download FREE Sample Report: Global Protein G, L, And A Resin Market – View in Detailed Research Report

Get Full Report: Global Protein G, L, And A Resin Market – View in Detailed Research Report

---

Outlook: The Future of Protein Affinity Media

The antibody purification sector is moving toward integrated, end‑to‑end solutions that combine affinity media with automated chromatography platforms. Regulatory bodies are tightening purity specifications, compelling manufacturers to offer resins that deliver higher recovery and lower contaminants. Meanwhile, the rise of personalized medicine and cell‑based therapies is amplifying demand for scalable, cost‑effective purification processes.

---

Future Trends Shaping the Market

• Digitalization of purification workflows through real‑time analytics and predictive maintenance.
• Development of reusable and recyclable resin formats to reduce environmental impact.
• Expansion of multi‑antibody purification strategies that combine Protein A, G, and L resins in a single platform.
• Growth of contract manufacturing services that bundle resin supply with process engineering.
• Adoption of green chemistry principles in resin synthesis to meet sustainability mandates.